Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Veracyte Inc (NQ: VCYT ) 36.59 +0.66 (+1.84%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,197,815 Open 36.77 Bid (Size) 34.00 (1) Ask (Size) 38.40 (2) Prev. Close 35.93 Today's Range 35.89 - 37.40 52wk Range 18.61 - 37.40 Shares Outstanding 67,473,870 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Veracyte Announces Third Quarter 2024 Financial Results Today 16:05 EST From Veracyte, Inc. Via Business Wire Veracyte to Participate in Upcoming Investor Conferences October 30, 2024 From Veracyte, Inc. Via Business Wire Performance YTD +33.54% +33.54% 1 Month +8.03% +8.03% 3 Month +35.27% +35.27% 6 Month +81.86% +81.86% 1 Year +52.39% +52.39% More News Read More Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024 October 16, 2024 From Veracyte, Inc. Via Business Wire Breaking Down Veracyte: 4 Analysts Share Their Views October 10, 2024 Via Benzinga A Glimpse Into The Expert Outlook On Veracyte Through 4 Analysts May 08, 2024 Via Benzinga New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men October 02, 2024 From Veracyte, Inc. Via Business Wire Tempus AI Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating September 16, 2024 Via Investor's Business Daily Topics Artificial Intelligence Exposures Artificial Intelligence New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer September 15, 2024 From Veracyte, Inc. Via Business Wire Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors September 04, 2024 From Veracyte, Inc. Via Business Wire Veracyte to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference August 26, 2024 From Veracyte, Inc. Via Business Wire Veracyte Named a Greater Bay Area Top Workplace by the San Francisco Chronicle August 26, 2024 From Veracyte, Inc. Via Business Wire Thermo Fisher Scientific Stock Sees RS Rating Jump To 81 August 13, 2024 Via Investor's Business Daily Lumen Tech & Upstart Are Among Top 7 Mid Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio? August 11, 2024 Via Benzinga Diagnostic Tests Maker Veracyte's Q2 Is 'All-Around Very Good Quarter': Analysts Maintain Bullish View August 07, 2024 Via Benzinga Shopify Posts Upbeat Earnings, Joins Axon Enterprise, Aspen Technology, Illumina, Global Payments And Other Big Stocks Moving Higher On Wednesday August 07, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday August 07, 2024 Via InvestorPlace VCYT Stock Earnings: Veracyte Beats EPS, Beats Revenue for Q2 2024 August 06, 2024 Via InvestorPlace Veracyte Announces Second Quarter 2024 Financial Results August 06, 2024 From Veracyte, Inc. Via Business Wire The 3 Best Personalized Nutrition Stocks to Buy Now July 24, 2024 Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence Veracyte to Release Second Quarter 2024 Financial Results on August 6, 2024 July 17, 2024 From Veracyte, Inc. Via Business Wire Trading SMID Biotech Stocks In A Volatile Market July 01, 2024 Via Talk Markets Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness June 10, 2024 Via Benzinga Veracyte Announces that New Afirma GRID Data Suggest Prognostic Ability of Molecular Testing for Thyroid Tumors June 03, 2024 From Veracyte, Inc. Via Business Wire Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer May 22, 2024 From Veracyte, Inc. Via Business Wire Veracyte to Participate in Upcoming Investor Conferences May 15, 2024 From Veracyte, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
